Immunohistochemical Signature Add Prognostic Value in Patients With Early and Intermediate Hepatocellular Carcinoma Underwent Curative Liver Resection

Hepatocellular carcinoma (HCC) is the third most lethal cancer worldwide; however, accurate prognostic tools are still lacking. We aimed to identify immunohistochemistry (IHC)-based signature as a prognostic classifier to predict recurrence and survival in patients with HCC at Barcelona Clinic Liver...

Descrición completa

Detalles Bibliográficos

Principais autores:	Yannan Bai, Yuane Lian, Xiaoping Chen, Jiayi Wu, Jianlin Lai, Funan Qiu, Songqiang Zhou, Zijing Zhu, Yifeng Tian, Yaodong Wang, Yinghong Yang, Maolin Yan
Formato:	Artigo
Idioma:	Inglês
Publicado:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Oncology
Assuntos:	hepatocellular carcinoma immunohistochemistry prognostic marker classifier prognosis
Acceso en liña:	https://www.frontiersin.org/articles/10.3389/fonc.2020.616263/full
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!